Eli Lilly and Company (LLY) closed at $1,409.39 on November 4, 2026, a decline of 0.15% from the prior session. The modest pullback came after a period of substantial gains that pushed the pharmaceutical giant's shares sharply higher over both the weekly and monthly timeframes.
Over the past seven days, LLY has advanced 9.98%, reflecting a broad surge in investor interest in the stock. The 30-day gain stands at an even more pronounced 23.20%, underscoring the strength of the move that has characterized recent trading activity.
The company's market capitalization stands at $1,256.83 billion as of the close, placing Eli Lilly among the largest publicly traded companies by that measure. The figure reflects the cumulative impact of the recent price appreciation across the company's outstanding shares.
Despite Tuesday's small decline, the stock's performance over the trailing month remains among the more notable moves in the large-cap space. Whether the near-term retreat represents a pause or a broader shift in momentum will likely become clearer in the sessions ahead.
